Document is current

Article History

Received: 24 November 2022

Accepted: 13 June 2023

First Online: 11 July 2023

Declarations

:

: C.J.P. and M.V.V. have received consulting fees and/or research grants from Merck Sharp and Dohme, Pfizer, WEST, and bioMérieux. All other authors declare no competing interests.

: All methods were carried out in accordance with relevant guidelines and regulations. Strict confidentiality was ensured at all times during data collection, storage, and analysis. Only the researchers had access to the data for their analysis. The study was approved by the ethics committees of the participating healthcare institutions (<i>Clínica Imbanaco, Hospital Universitario Austral, Hospital Médica Sur, Instituto Nacional de Enfermedades Neoplasicas, Universidade Federal de São Paulo, Hospital Rafael Ángel Calderon Guardia, Pontificia Universidad Católica de Chile</i>). Universidad El Bosque Research and Ethics Committee waived the requirement for written informed consent for participants in this study, due to its classification as minimal risk and the use of data limited to patient care, as per national legislation and current institutional requirements.

: Not applicable.